ClinicalTrials.gov
public full text
Public Domain
Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients
These study is designed to evaluate the tolerability and efficacy of sirolimus (rapamycin) in combination with low-dose aracytin in elderly AML.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia#800429
- Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML#1114177
- Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia#853563
- Phase I Study in RAD 001 Patients With Relapse AML#1173107
- Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia#979436
Record · ID 881557
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive